Technical Analysis of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) for the period of 9-Day stands at 78.65% while the stochastic %D for the same period stands at 77.75%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system.  The company seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products.  Adamas is currently developing ADS-5102, its lead wholly-owned product candidate, for the treatment of levodopa-induced dyskinesia (LID) associated with Parkinson’s disease and for the treatment of major symptoms associated with multiple sclerosis in patients with walking impairment.  The company’s portfolio also includes Namzaric and Namenda XR, two approved products with Forest Laboratories Holdings Limited, an indirect wholly-owned subsidiary of Allergan plc. Forest is responsible for marketing both products in the United States under an exclusive license from Adamas.

Previous Day Activity Analysis

On the last trading day, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) opened the session at $27.52 and after going up 3.75% closed at $28.79. The stock gained 1.27 points in the last trade.

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)’s stock fluctuated in the range of $27.30 and $28.88 during the previous active session. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) traded with the volume of 909844 with average volume of 1.28 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 0.82 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.58 and 73.39 respectively.

Currently the Insider Ownership of the shares of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) is at 0.3% and the shares outstanding are 22.46 Million.

Important Ratio Analysis

Some important ratios to consider here for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 3653.24 and 7.56 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.23 and 0 correspondingly.

The Quick Ratio of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) stands at 8.3 while the Current Ratio depicts the value of 8.3.

Return on Assets ROA of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) is at -53.8% whereas, Return on Equity ROE and Return of Investment ROI of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) stand at -68% and -46% respectively.

Stock Performance Analysis

The stock performance of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) on the basis of 5 day trade show the jump of 4.88% whereas, the monthly performance of the stock shows increase of 51.37%.

The quarterly performance of the stock remained in green zone with the value of 96.12% while six month performance of the shares of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) remained bullish with the count of 88.42%.

The yearly and YTD performance of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) remained up at 80.61% and 70.36% respectively.